|Six New Members Named to National Neurology
The National Institute of Neurological Disorders and Stroke (NINDS)
has appointed six new members to its major advisory panel, the
National Advisory Neurological Disorders and Stroke Council. The
NINDS, a component of the National Institutes of Health (NIH),
is the nationís primary supporter of basic, translational, and
clinical research on the brain and nervous system. NINDS Director
Story Landis, Ph.D., formally introduced the new members, who will
serve through July 2010, at the Councilís September 14, 2006 meeting.
The National Advisory Neurological Disorders and Stroke Council
meets three times each year to review applications from scientists
seeking financial support for biomedical research and research
training on disorders of the brain and nervous system. Members
also advise the Institute on research program planning and priorities.
The 18-member Council is composed of physicians, scientists, and
representatives of the public. The new members are:
Susan Axelrod, M.B.A., is president and founder
of Citizens United for Research in Epilepsy (CURE), a non-profit
organization founded by mothers of children with severe epilepsy.
Since its inception in 1998, CURE has raised more than $3 million
to fund research into finding cures and worked to raise public
awareness to the prevalence and devastation of epilepsy. Ms. Axelrod
helped organize and cosponsor the NIH conference, ďCuring Epilepsy-Focus
on the Future,Ē in March 2000 and is helping to plan the second
NIH conference, ďCuring Epilepsy 2007: Translating Discoveries
into Therapies,Ē to be held in March 2007.
Lucie Bruijin, Ph.D., is science director and
vice president of The Amyotrophic Lateral Sclerosis (ALS) Association.
This national non-profit organization is the largest private source
of funding for ALS-specific scientific research in the world, having
awarded nearly $30 million since 1995. Dr. Bruijin received a bachelorís
degree in pharmacy from Rhodes University, South Africa, and a
masterís degree in neuroscience and a doctorate in biochemistry
at the University of London. She brings to the Advisory Council
a unique combination of scientific skill and experience. She has
developed and characterized various model systems of neurodegenerative
diseases, including one of the mouse models of ALS.
Ralph G. Dacey, Jr., M.D., is the Henry G. and
Edith R. Schwartz Professor and chairman of the Department of Neurological
Surgery at Washington University School of Medicine in St. Louis,
Missouri. He is also neurosurgeon-in-chief at Barnes-Jewish Hospital.
He received his bachelorís degree at Harvard University and his
medical degree at the University of Virginia. Dr. Dacey is secretary
of the American Academy of Neurological Surgery, former chairman
of the American Board of Neurological Surgery, and a past president
of the Congress of Neurological Surgeons. A leader in the field
of cerebrovascular neurosurgery, Dr. Daceyís many honors include
the international Grass Foundation award, which recognizes outstanding
and continued contributions to research in neurosurgery.
Edgar J. Kenton, III, M.D., is director of the
Stroke Prevention Intervention Research Program at the Morehouse
School of Medicine in Atlanta, Georgia. This NIH-funded program
addresses racial and geographic disparities related to stroke and
cerebrovascular disease in the United States and creates community-based
prevention and intervention strategies. He received his undergraduate
degree from Rutgers University and his medical degree from Cornell
Medical College. Dr. Kenton is past president of the American Board
of Psychiatry and Neurology and served on the board of directors
of the American Academy of Neurology and the American Heart Association.
He presently serves as a director on the American Board of Medical
Specialties and the Accreditation Council of Continuing Medical
Caroline M. Tanner, M.D., Ph.D., is director
of clinical research at The Parkinsonís Institute in Sunnyvale,
California. She is also a clinical lecturer in the Department of
Health Research and Policy at Stanford University. She earned her
medical degree at Loyola University and her doctorate from the
University of California at Berkeley. Her many memberships in medical
societies include the Movement Disorder Society and American Society
for Experimental Therapeutics (both as a founding member). A noted
epidemiologist and biostatistician, Dr. Tanner serves on the editorial
board of the journal Neuroepidemiology and on the Scientific
Advisory Board of the Michael J. Fox Foundation. She fills a vacancy
from last yearís Council and serves through July 2009.
Gary Westbrook, M.D., is co-director of the Vollum
Institute, a privately endowed research unit of the Oregon Health & Science
University. He is also a professor of neurology in the Universityís
School of Medicine. His research focuses on synaptic transmission
in the central nervous system. Dr. Westbrook has clinical training
in internal medicine and in neurology. He received his undergraduate
degree from Miami University (Ohio) and has degrees in biomedical
engineering and medicine from Case Western Reserve University.
Among his honors and awards is the prestigious Senator Jacob Javits
Award in the Neurosciences. Dr. Westbrook is editor-in-chief of
the Journal of Neuroscience.
The National Institute of Neurological Disorders and Stroke
is the nationís primary funder of research on the brain and nervous
system. More information about the NINDS and its mission is available
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.